US Broker Ratings

Legend Biotech Corporation (LEGN) Stock Analysis: A Promising 138.98% Upside Potential in Biotechnology

Legend Biotech Corporation (NASDAQ: LEGN) is garnering attention from investors with its remarkable growth prospects in the biotechnology sector. With a market capitalization of $5.92 billion, Legend Biotech is making..

Cencora, Inc. (COR) Stock Analysis: Exploring a 9.94% Potential Upside in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a pivotal player in the healthcare distribution sector, presents an intriguing opportunity for investors. With a robust market capitalization of $58.7 billion, this U.S.-based company has..

Globus Medical, Inc. (GMED) Stock Analysis: Unpacking a 32.77% Potential Upside

Globus Medical, Inc. (NYSE: GMED) is catching the eye of investors with a compelling potential upside of 32.77%, as suggested by analyst ratings. With a robust market cap of $8.17..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unpacking a 9% Potential Upside and Promising Growth Prospects

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is capturing the attention of global investors with its innovative oncology treatments and promising growth metrics. With a current..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with a Strong Revenue Growth and Robust Pipeline

Incyte Corporation (NASDAQ: INCY), a leading biopharmaceutical innovator, continues to grab attention in the healthcare sector with its significant contributions to the biotechnology industry. With a market capitalization of $16.96..

Humana Inc. (HUM) Stock Analysis: Navigating Growth and Strategic Prospects in the Healthcare Sector

Humana Inc. (NYSE: HUM), a key player in the U.S. healthcare plans industry, continues to demonstrate robust business operations while navigating the complexities of the sector. With a market capitalization..

Elevance Health, Inc. (ELV) Stock Analysis: A Healthcare Giant with a 3.11% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, has been making significant strides in the sector with its comprehensive range of health benefits and services...

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a Potential 37.82% Upside in Healthcare

For investors with an eye on the healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents a compelling opportunity. As a leading provider of home and alternate site infusion services..

Gilead Sciences, Inc. (GILD) Stock Analysis: Assessing an 11.10% Upside Potential

Gilead Sciences, Inc. (NASDAQ: GILD), a titan in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations in the biopharmaceutical landscape. The company’s current..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with Stable Revenue Growth and Modest Upside

Teleflex Incorporated (NYSE: TFX) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Wayne, Pennsylvania, Teleflex designs, develops, and manufactures single-use..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring a 17% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a stalwart in the healthcare sector, has been capturing investor attention with its robust distribution network and innovative solutions that support healthcare providers and manufacturers..

Glaukos Corporation (GKOS) Investor Outlook: Exploring a 38% Potential Upside Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector specializing in medical devices, has garnered significant attention from investors due to its innovative approach in treating ophthalmic disorders...

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 6.9% Potential Upside Amid Strong Revenue Growth

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, continues to capture investor attention with its robust revenue growth and promising upside potential...

Teva Pharmaceutical (TEVA) Stock Analysis: A 21% Upside Potential Amidst a Challenging Market

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the global pharmaceutical arena, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. Despite its current price of..

Encompass Health Corporation (EHC) Stock Analysis: A Solid Healthcare Play with 12% Potential Upside

Encompass Health Corporation (NYSE: EHC) stands out within the healthcare sector as a robust player in the medical care facilities industry. With a market capitalization of $12.41 billion, this Birmingham,..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Powerhouse with 10.5% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors as it continues to make waves in the healthcare sector, specifically within the biotechnology industry. The company, based in..

Bruker Corporation (BRKR)

⚠️ No article content returned.

..

DaVita Inc. (DVA) Stock Analysis: Strong Revenue Growth and a 17% Upside Potential

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specifically within medical care facilities, is making waves with its financial performance and promising analyst projections. With a market..

The Cooper Companies, Inc. (COO) Stock Analysis: Harnessing an 18% Upside in the Healthcare Sector

Investors with an eye on the healthcare sector would do well to consider The Cooper Companies, Inc. (NYSE: COO), a stalwart in the Medical Instruments & Supplies industry. With a..

Illumina, Inc. (ILMN) Stock Analysis: Exploring Its Growth Potential and Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN) stands at the forefront of the healthcare sector, specifically within the diagnostics and research industry. Known for its pioneering sequencing and array-based solutions for genetic and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds